Transfusing Neonates Based on Platelet Mass in the Neonatal Intensive Care Unit: A Randomized Pilot Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Thrombocytopenia
- Sponsor
- Christiana Care Health Services
- Enrollment
- 50
- Locations
- 4
- Primary Endpoint
- Total number of transfusions
- Status
- Completed
- Last Updated
- 15 years ago
Overview
Brief Summary
Thrombocytopenia (low platelet count) is common in the neonatal intensive care unit. Commonly, the decision of when to transfuse platelets is based on platelet number. Recently, Christensen et al (2006) proposed using transfusion guidelines based on platelet mass rather than platelet number. By using platelet size as a guide of when to give platelets, we may be able to decrease the amount platelet transfusions needed.
This study is investigating using platelet size rather than platelet number as a guideline for transfusing platelets in infants who are hospitalized in a NICU (neonatal intensive care unit). After obtaining parental informed consent, thrombocytopenic infants will be randomized to one of two groups. 1: Transfusion based on platelet number; 2: transfusion based on a combination of platelet number and platelet mass. In each group the decision to transfuse platelets will be made using a slightly different, yet strict set of transfusion rules.
The objective is to determine the feasibility, rate of bleeding complications and compliance of transfusing neonates based on platelet mass rather than platelet number.
The investigators hypothesize that transfusing platelets based on platelet mass will not increase bleeding complications and will reduce the number of transfusions in thrombocytopenic neonates.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Thrombocytopenic infants
Exclusion Criteria
- •Major congenital anomalies
Outcomes
Primary Outcomes
Total number of transfusions
Time Frame: During NICU hospitalization
Secondary Outcomes
- Compliance with transfusion guidelines(During NICU hospitalization)
- Bleeding outcomes(While the infant is thrombocytopenic)